GH1 and metabolic syndrome: Deficiency in growth hormones, obesity, and metabolic disorders including dyslipidemia, metabolic syndrome, diabetes, and hyperinsulinemia are commonly observed in surviving pediatric cancer patients who received radiotherapy with the pituitary-hypothalamic regions situated in the field of irradiation [5,6].